The deal that could value the Asian healthcare services company at up to US$1bil. — Reuters
SINGAPORE: Global investment firm Hillhouse is emerging as one of the final few bidders for Everlife Holdings in a deal that could value the Asian healthcare services company at up to US$1bil, two people with knowledge of the matter say.
The deadline of the final binding bid for Everlife, which offers products and solutions to clinical and scientific laboratories in South and South-East Asia, is Jan 31, according to one of the sources.
Both sources declined to be named as the bidding details remained confidential.
The other bidders include international investment firm Vitruvian Partners, according to one of the sources.
Reuters reported in October that Singapore-headquartered private-equity firm Everstone Capital has hired BDA Partners to run the sale of Everlife.
Hillhouse, Vitruvian and BDA declined to comment. Everstone and Everlife did not immediately respond to requests seeking comment. — Reuters
